In Ewing sarcoma, ERG fusions result in replacement of the C-terminus of EWS by the DNA-binding domain of ERG resulting in loss of endogenous ERG promoter activity, causing dysregulation of ERG and its target genes [7]. The gene discussed is ERG; the disease is Ewing sarcoma.